The Venture Codex Logo

The Venture Codex

Overview

Venture capital investment in human health companies.

Founded

2007

Deals · 12mo

1

Stage focus

Series A
Series B
Series C

Geographic focus

Belgium
Germany
Portugal
Switzerland
...

Sector focus

Financial Services
Venture Capital

Investment portfolio

52rounds
NAMEDATESIZE
Rouge Therapeutics
Oct 2026Participated
$58 MSeries A
Nutrium
Sep 2025Led
$12 MSeries A
Inflammatix
Sep 2024Participated
$57 MSeries E
Caresyntax
Aug 2024Participated
$180 MDebt
CatalYm
Jul 2024Participated
$150 MSeries D
HepaRegeniX
Jul 2024Led
$16 MSeries C
Memo Therapeutics
May 2024Participated
$22 MSeries C
Tonic App
Apr 2024Participated
$12 MSeries A
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
CatalYm
Nov 2022Participated
$51 MSeries C
Scenic Biotech
Mar 2022Led
$31 MSeries A
Memo Therapeutics
Feb 2022Participated
$40 MSeries B
Rouge Therapeutics
Oct 2026Participated
$58 MSeries A
Nutrium
Sep 2025Led
$12 MSeries A
Inflammatix
Sep 2024Participated
$57 MSeries E
Caresyntax
Aug 2024Participated
$180 MDebt
CatalYm
Jul 2024Participated
$150 MSeries D
HepaRegeniX
Jul 2024Led
$16 MSeries C
Memo Therapeutics
May 2024Participated
$22 MSeries C
Tonic App
Apr 2024Participated
$12 MSeries A
Memo Therapeutics
Nov 2023Participated
$28 MSeries C
CatalYm
Nov 2022Participated
$51 MSeries C
Scenic Biotech
Mar 2022Led
$31 MSeries A
Memo Therapeutics
Feb 2022Participated
$40 MSeries B
52
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Vesalius Biocapital: 52 funding rounds are recorded in the selected participation categories.All available history.
Vesalius Biocapital: 52 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A76
Series B77
Series C+413
Other Equity33
Debt01

Monthly Deal Activity

Vesalius Biocapital: 52 deals are recorded across 205 months.All available history.
Vesalius Biocapital: 52 deals are recorded across 205 months. All available history
MonthDeals
Oct '091
Nov '091
Dec '090
Jan '100
Feb '100
Mar '100
Apr '100
May '100
Jun '101
Jul '100
Aug '100
Sep '100
Oct '100
Nov '100
Dec '100
Jan '110
Feb '111
Mar '110
Apr '110
May '112
Jun '110
Jul '110
Aug '110
Sep '111
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '121
Apr '121
May '120
Jun '120
Jul '121
Aug '120
Sep '120
Oct '120
Nov '121
Dec '120
Jan '130
Feb '130
Mar '130
Apr '130
May '130
Jun '131
Jul '130
Aug '130
Sep '130
Oct '131
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '141
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '141
Nov '142
Dec '140
Jan '151
Feb '150
Mar '150
Apr '151
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '151
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '160
Jun '160
Jul '160
Aug '160
Sep '160
Oct '161
Nov '160
Dec '160
Jan '171
Feb '170
Mar '171
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '171
Dec '170
Jan '180
Feb '180
Mar '180
Apr '181
May '180
Jun '180
Jul '180
Aug '180
Sep '181
Oct '180
Nov '181
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '191
Aug '190
Sep '190
Oct '190
Nov '190
Dec '191
Jan '201
Feb '202
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '201
Nov '201
Dec '200
Jan '210
Feb '211
Mar '210
Apr '211
May '210
Jun '210
Jul '211
Aug '210
Sep '211
Oct '211
Nov '210
Dec '210
Jan '220
Feb '221
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '241
May '241
Jun '240
Jul '242
Aug '241
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

Vesalius Biocapital: Health & Life Sciences is the largest displayed sector by deal count (50 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Vesalius Biocapital: Health & Life Sciences is the largest displayed sector by deal count (50 deals). All available history
SectorDeals
Health & Life Sciences50
Enterprise Software6
AI & Machine Learning6
Data, Analytics & IT6
Space & Frontier Tech4
Networks, Cloud & Communication3
Hardware & Robotics3
Manufacturing3
E-Commerce & Retail2
Cybersecurity & Privacy2
Social & Community Platforms1

Deal Size Distribution

Vesalius Biocapital: 52 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Vesalius Biocapital: 52 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M5
$5M-$10M10
$10M-$25M19
$25M-$50M11
$50M-$100M4
$100M-$250M3
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Vesalius Biocapital: Europe has the largest recorded deal count among the displayed regions (43 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Vesalius Biocapital: Europe has the largest recorded deal count among the displayed regions (43 deals). All available history
RegionDeals
Europe43
United States8
Canada1
Vesalius Biocapital: 20 co-investors are shown, with SRIW sharing 9 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Vesalius Biocapital: Led accounts for 40% and participating for 60% of round participation.All available history.
Vesalius Biocapital: Led accounts for 40% and participating for 60% of round participation. All available history
CategoryDeals (count)Share (%)
Led2140%
Participating3160%
Vesalius Biocapital: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
Vesalius Biocapital: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead733%
Co-led1467%

Team

Alain Parthoens

Managing Partner

David Braga Malta

Venture Partner

Fei Tian

Analyst

Marc Lohrmann

Managing Partner

Stephane Verdood

Managing Partner